|
Volumn 7, Issue 9, 2000, Pages 733-742
|
Aryl ureas represent a new class of anti-trypanosomal agents
|
Author keywords
Cysteine protease; DOCK; Structure based drug design; Thiourea; Trypanosomal disease; Urea
|
Indexed keywords
ANTITRYPANOSOMAL AGENT;
CRUZAIN, TRYPANOSOMA CRUZI;
CYSTEINE PROTEINASE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
IMIDAZOLE DERIVATIVE;
PROTOZOAL PROTEIN;
SULFONAMIDE;
THIOUREA;
ANIMAL;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
COMPARATIVE STUDY;
DRUG DESIGN;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
METABOLISM;
PROTEIN CONFORMATION;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
TRYPANOSOMA BRUCEI;
TRYPANOSOMA CRUZI;
ANIMALS;
CYSTEINE ENDOPEPTIDASES;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
IMIDAZOLES;
MODELS, MOLECULAR;
PROTEIN CONFORMATION;
PROTOZOAN PROTEINS;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONAMIDES;
THIOUREA;
TRYPANOCIDAL AGENTS;
TRYPANOSOMA BRUCEI BRUCEI;
TRYPANOSOMA CRUZI;
ANIMALIA;
TRYPANOSOMA;
TRYPANOSOMA BRUCEI;
TRYPANOSOMA CRUZI;
|
EID: 0033830860
PISSN: 10745521
EISSN: None
Source Type: Journal
DOI: 10.1016/S1074-5521(00)00018-1 Document Type: Article |
Times cited : (105)
|
References (45)
|